Conclusion
®, chronic disease
CHRONIC DISEASE
This evaluation indicates that telehealth care could be cost-effective when the program covers a large population. The difference and cost savings in hospitalisation is due to both a reduction in the number of acute admissions and a reduction in LOS in the intervention group. Although there are excellent telehealth monitoring programs in place, there are limited programs that have demonstrated cost-effectiveness analysis. We recommend that future telehealth interventions for chronic disease management evaluations include a cost-effectiveness analysis at immediate, mid-term and long-term time points and target a larger study sample to observe the real-life effect.We wish to acknowledge the valuable contributions and support of:• Prof Peter Martin, School of Medicine Deakin University• Ms Marita Reed, Project Manager, Barwon Health• Ms Rebecca Eastgate, Project Manager, Barwon Health• A/Prof Rob Malon, Deakin University• Ms Anna Dowd, Clinical Trial Coordinator, Barwon Health• Prof Frances Quirk, Director of Research, Barwon Health• Dr Stephen Lane, Research Fellow, University of Melbourne• The TELUS® RPM team Canada and Australia for providing the platform for service delivery• The Personalised Healthcare pilot project was supported by the Victorian Government